Major step towards individual cancer immunotherapy
T cells (left) become active in the body only when they recognise a peptide (blue, centre) located on one of the immune system’s sentinel cells (right). The ETH scientists repurposed sentinel cells in such a way that they indicate which peptides the T cells recognise. Photo credit: MedicalXpress/Science Photo Library / Keith Chambers
Medicine has great hopes for personalised cancer immunotherapy. The idea is to have a vaccine prompt the immune system to fight a tumour. Scientists at ETH Zurich have developed a method that allows them to determine which molecules are suited to patient-specific immunisation. Read more.
Published March 29, 2019 by Medical Xpress
‹ More News